Cingulate (CING)
Develops once-daily ADHD medicines using a multi-core timed-release platform.
$5.00
vs last close−0.14 (−2.82%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 12.58% | 1.83M shares | |
|---|---|---|---|
| 38 holders · as of Jun 30, 2026 | |||
| Insiders | 1.78% | 259.3K shares | |
| 7 holders · as of Jun 8, 2026 | |||
| Strategic holders | 26.52% | 3.86M shares | |
| 1 holder · as of Mar 26, 2026 | |||
| Other | 59.12% | 8.60M shares | |
| remainder | |||
14.54M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
38 holders · 1.83M shares · 11 new positions · 26 increased · 4 reduced · 4 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 570.9K | 3.93% | +261.9K | Aug 13, 2026 |
| Chicago Partners Investment Group LLC | 188.4K | 1.30% | +169.7K | Jul 30, 2026 |
| Raymond James Financial Inc | 166.9K | 1.15% | +166.9Knew | Aug 14, 2026 |
| Kestra Advisory Services, LLC | 151.5K | 1.04% | +11.5K | Jul 28, 2026 |
| Geode Capital Management, LLC | 144.6K | 0.99% | +43.3K | Aug 12, 2026 |
| Renaissance Technologies LLC | 127.5K | 0.88% | +95.6K | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | 79.2K | 0.54% | +29.1K | Aug 13, 2026 |
| BlackRock, Inc. | 53.1K | 0.37% | +29.9K | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Falcon Creek Capital Advisor LLCincl. Falcon Creek Technology Fund I, LP, Ginkgo Capital Global Fund SPC - Xtalpi AI Fund SP | 28.50% | 3.86M | 13D | Mar 26, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Feb 13, 2026 | Thomas Jeffrey Hargrovesdirector | Purchase · 2 lots | 175,097 | $5.04 | 175,289 |
| Feb 6, 2026 | Matthew Bramsofficer: EVP and Chief Medical Officer | Purchase · 2 lots | 3,502 | $5.04 | 6,212 |
| Feb 6, 2026 | Shane J. Schafferdirector, officer: Chief Executive Officer | Purchase · 2 lots | 12,256 | $5.04 | 15,622 |
| Feb 6, 2026 | Jennifer L. Callahanofficer: SVP and CFO | Purchase · 2 lots | 8,755 | $5.04 | 8,950 |
| Feb 6, 2026 | Peter J. Werthdirector | Purchase · 2 lots | 35,019 | $5.04 | 133,013 |
House and Senate disclosures
Not reported.